Growing Dependency of Online Retailers on Efficient Shipping Solutions Contributing to Rising Profitability of Courier & Delivery Service BusinessesRockville, MD , Jan. 29, 2025 (GLOBE NEWSWIRE) -- The global Courier & Delivery Services Market is analyzed at US$ 507.39 billion in 2024. The market has been projected to expand at a CAGR of 5.8% to reach a value of US$ 895.23 billion by the end of 2034.according to the latest industry analysis released by Fact.MR, a market research and competitive intelligence ...

The Company moves ahead with its investment in Kaspa Mining Limited further building its Kaspa Mining OperationsVancouver, B.C., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Dynamite Blockchain Corp. (the “Company” or “Dynamite”) (CSE: KAS) is pleased to announce that, further to its news release dated December 2, 2024, it has terminated its previously proposed acquisition (the “Original Acquisition”) of 100% of the outstanding shares of Kaspa Mining Limited (“Kaspa Mining”) and entered into a new arm’s length share p ...

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the "Company" or "Calibre"), a growing mid-tier gold producer, is pleased to announce a maiden Mineral Resource estimate for its 100% owned Talavera Gold Deposit (“Talavera”), which has, historically, produced 800,000 ounces gold and is located 3 kilometres from the Limon mill. The Mineral Resource, which will be included in the Company’s 2024 year-end Mineral Resource statement, includes 3,847,000 ...

STAFFORD, Texas, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following update on the expansion of the clinical trial into Europe. The Company's application to add an additional 11 sites in Spain, Germany, and Poland has been formally approved by EMA. The academ ...

WASHINGTON, Jan. 29, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2024.  All results in this release reflect only continuing operations unless otherwise noted. Key Fourth Quarter 2024 Results Net earnings were $1.1 billion, or $1.49 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $2.14. Revenues increased 2.0% year-over-year to $6.5 billion and non-GAAP core revenue increased 1.0%. ...

MONTCLAIR, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital”) notes that its Board of Directors (the “Board”), including the Special Committee of the Board, has evaluated the non-binding proposal from Source Capital issued on January 24, 2025 (the “Source Proposal”), pursuant to the requirements of Section 7.10 of the Agreement and Plan of Merger by and among 180 Degree Capital Corp., Mount Logan Capital Inc. (“Mount Logan”), Yukon New Parent, Inc., Polar M ...

VIRGINIA BEACH, Va., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Armada Hoffler (NYSE: AHH) announced strategic steps in reducing exposure to variable rate debt as the company continues to execute its balance sheet management strategy. Since the end of the third quarter of 2024, the Company has: Executed a $150 million floating-to-fixed rate swap, effective January 2, 2025, with a 2-year term, and a swap fixed rate of 2.5%. The Company bought down the rate for a total cost of $4.6 million. With this trade, Armada Hof ...

STAFFORD, Texas, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following update on the expansion of the clinical trial into Europe. The Company's application to add an additional 11 sites in Spain, Germany, and Poland has been formally approved by EMA. The acade ...

WAUKESHA, Wis., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Generac Holdings Inc. ("Generac") (NYSE: GNRC), a leading global designer, manufacturer, and provider of energy technology solutions and other power products, today announced plans to release its fourth quarter and full-year 2024 financial results before the market opens on Wednesday, February 12, 2025. Generac management will hold a conference call at 10:00 a.m. EST on that day to discuss highlights of this earnings release. A webcast of the conference call ...

Lawsuit Overview - The law firm Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against BioAge Labs Inc for alleged violations of the Securities Act of 1933 [1] - Investors who purchased BioAge Labs stock pursuant to its IPO have until March 10 2025 to seek appointment as lead plaintiff [1] - The lawsuit is captioned Soto v BioAge Labs Inc No 25-cv-00196 (ND Cal) [1] IPO and Stock Performance - BioAge Labs sold 1265 million shares at $1800 per share in its IPO held on September 26 2024 [2] - The stock price fell more than 76% after the company announced discontinuation of its STRIDES Phase 2 study on December 6 2024 [4] - By the commencement of the lawsuit BioAge Labs stock was trading at or around $582 per share well below the IPO price [4] Allegations - The lawsuit alleges that BioAge Labs IPO offering documents were materially false and/or misleading [3] - The company allegedly represented there were no safety concerns and expected to meet primary endpoint goals in its STRIDES clinical trial [3] - The STRIDES Phase 2 study of investigational drug candidate azelaprag was discontinued after liver transaminitis was observed in some subjects [4] Lead Plaintiff Process - Any investor who purchased BioAge Labs stock pursuant to the IPO can seek appointment as lead plaintiff [5] - The lead plaintiff is generally the movant with the greatest financial interest in the relief sought [5] - The lead plaintiff acts on behalf of all class members and can select a law firm to litigate the case [5] Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm representing investors in securities fraud cases [6] - The firm has recovered $66 billion for investors in securities-related class action cases in the last four years [6] - Robbins Geller has 200 lawyers in 10 offices and has obtained many of the largest securities class action recoveries in history [6]